The mortality rate due to liver malignant neoplasms in the UK is projected to rise steadily from 13.0 male deaths per 100,000 men in 2024 to 14.4 in 2028. This indicates a consistent upward trend, with a year-on-year increase of approximately 2.9% in 2025, 2.2% in 2026, 2.9% in 2027, and 2.1% in 2028. Though actual data for 2023 is not provided, this steady rise suggests a growing public health challenge.

Future trends to watch for:

Increased focus on preventive healthcare and liver cancer screening programs.
Impact of healthcare policies and advancements in treatment options.
Role of lifestyle factors and public awareness in mitigating risk factors associated with liver cancer.
Potential innovations in medical research and technology to reduce mortality rates.